Skip to main content
Year archive

ARGENT BIOPHARMA LIMITED — 2020 filings

All 139 regulatory filings released by ARGENT BIOPHARMA LIMITED (RGT) in 2020, sourced directly from the official regulator.

139 Filings
2020 Period
2020 filings (139)
Filing Released Lang
MGC Pharma to receive grant for Malta production facility 2 pages 219.0KB
Regulatory Filings
2020-12-21 English
Appendix 2A 16 pages 420.9KB
Regulatory Filings
2020-12-21 English
ArtemiC Phase II Clinical Trial Results 6 pages 299.3KB
Regulatory Filings
2020-12-14 English
Appendix 2A 16 pages 420.3KB
Regulatory Filings
2020-12-10 English
Completion of Unmarketable Parcel Share Sale Facility 2 pages 196.7KB
Regulatory Filings
2020-12-08 English
ArtemiC Phase II Clinical Trial Results Update 2 pages 211.6KB
Regulatory Filings
2020-12-06 English
MGC Pharma to benefit from UN vote to reschedule Cannabis 2 pages 210.0KB
Regulatory Filings
2020-12-02 English
MGC Nutraceuticals Sale Update 2 pages 214.5KB
Regulatory Filings
2020-12-01 English
Amended MGC Nutraceuticals Sales Update 2 pages 215.4KB
Regulatory Filings
2020-12-01 English
Company Secretary Appointment 1 page 150.7KB
Regulatory Filings
2020-11-29 English
Issue of Securities - Appendix 2A 16 pages 307.5KB
Regulatory Filings
2020-11-23 English
MGC PHARMA COMPLETES ACQUISITION OF TELEHEALTH PLATFORM MCC 2 pages 184.3KB
Regulatory Filings
2020-11-22 English
Drawdown of $3.5m Convertible Note 1 page 130.3KB
Regulatory Filings
2020-11-22 English
Proposed issue of Securities - MXC 9 pages 38.0KB
Regulatory Filings
2020-11-22 English
Prospectus 46 pages 423.0KB
Regulatory Filings
2020-11-22 English
FURTHER SUCCESSFUL RESULTS FROM GLIOBLASTOMA RESEARCH 5 pages 513.3KB
Regulatory Filings
2020-11-16 English
Conversion of Convertible Notes - Appendix 2A 16 pages 298.6KB
Regulatory Filings
2020-11-12 English
COMPLETION OF PHASE II CLINICAL TRIAL ON COVID-19 PATIENTS 3 pages 198.0KB
Regulatory Filings
2020-11-04 English
AGM Presentation 19 pages 1.3MB
Regulatory Filings
2020-11-03 English
Results of Annual General Meeting 3 pages 372.3KB
Regulatory Filings
2020-11-03 English
Constitution 73 pages 632.5KB
Regulatory Filings
2020-11-03 English
MGC Pharma AGM Information and Webinar 1 page 136.4
Regulatory Filings
2020-10-27 English
Annual Report 2020 80 pages 8.2MB
Regulatory Filings
2020-10-27 English
September Quarterly Activity and Cashflow Report 10 pages 367.3KB
Regulatory Filings
2020-10-26 English
Unmarketable Parcel Share Sale Update 1 page 135.0K
Regulatory Filings
2020-10-25 English
MGC PHARMA DELIVERS RECORD CONSECUTIVE WEEKLY SALES GROWTH 3 pages 275.5KB
Regulatory Filings
2020-10-19 English
ARTEMIC HISTOLOGY ON RATS CONFIRM NO PATHOLOGICAL IMPACT 4 pages 252.0KB
Regulatory Filings
2020-10-13 English
FIRST HIGH THC PRODUCTS SHIPPED DIRECT TO BRAZIL PATIENTS 3 pages 192.7KB
Regulatory Filings
2020-10-11 English
MGC PHARMA LAUNCHES CANNEPIL APP 3 pages 224.5KB
Regulatory Filings
2020-10-06 English
Notice of Annual General Meeting/Proxy Form 42 pages 672.6KB
Regulatory Filings
2020-10-01 English
Letter to Shareholders - Upcoming Annual General Meeting 3 pages 312.2KB
Regulatory Filings
2020-10-01 English
Annual Report for the year ended 30 June 2020 66 pages 1.4MB
Regulatory Filings
2020-09-30 English
Appendix 4G and Corporate Governance Statement 23 pages 368.9KB
Regulatory Filings
2020-09-30 English
UPDATE ON ARTEMIC PHASE II TRIAL ON COVID-19 PATIENTS 4 pages 213.2KB
Regulatory Filings
2020-09-27 English
MXC WELCOMES NEW FCA GUIDANCE FOR CANNABIS SECTOR IN THE UK 2 pages 179.9KB
Regulatory Filings
2020-09-20 English
Issue of Securities - Appendix 2A 16 pages 337.8KB
Regulatory Filings
2020-09-14 English
MXC WELL POSITIONED FOR TGA DOWN-SCHEDULE OF CBD PRODUCTS 2 pages 195.3KB
Regulatory Filings
2020-09-13 English
$15M FINANCE FACILITY TO FUND REVENUE GROWTH FOR KEY MARKETS 3 pages 198.8KB
Regulatory Filings
2020-09-09 English
Proposed issue of Securities - MXC 7 pages 33.8KB
Regulatory Filings
2020-09-09 English
Prospectus 46 pages 392.8KB
Regulatory Filings
2020-09-09 English
Trading Halt 2 pages 538.8KB
Regulatory Filings
2020-09-07 English
Initial Director's Interest Notice - Appx 3X - Evan Hayes 2 pages 177.2KB
Regulatory Filings
2020-09-03 English
BIOPHARMA APPOINTMENTS STRENGTHEN BOARD AND LEADERSHIP TEAM 3 pages 212.5KB
Regulatory Filings
2020-08-31 English
Appendix 4E and Preliminary Unaudited Financial Report 12 pages 335.1KB
Regulatory Filings
2020-08-30 English
JV TO BE ESTABLISHED FOR REGISTRATION OF ARTEMIC IN RUSSIA 4 pages 213.5KB
Regulatory Filings
2020-08-24 English
COVID-19 Interim Trial Results Meet All Primary Objectives 8 pages 418.7KB
Regulatory Filings
2020-08-19 English
Trading Halt 2 pages 177.3KB
Regulatory Filings
2020-08-18 English
UK DISTRIBUTION AGREEMENT SIGNED FOR MGC PHARMA MEDICINES 2 pages 240.3KB
Regulatory Filings
2020-08-13 English
Change of Director's Interest Notice - Appendix 3Y x 2 5 pages 216.3KB
Regulatory Filings
2020-08-12 English
Proposed issue of Securities - MXC 9 pages 36.7KB
Regulatory Filings
2020-08-11 English
Issue of Securities - Appendix 2A 15 pages 325.5KB
Regulatory Filings
2020-08-11 English
Issue of Securities 2 pages 212.6KB
Regulatory Filings
2020-08-11 English
Prospectus 35 pages 397.2KB
Regulatory Filings
2020-08-11 English
STUDY CONFIRMS EFFECTIVENESS OF ARTEMIC ON HUMAN IMMUNE CELL 6 pages 392.2KB
Regulatory Filings
2020-08-06 English
Pause in trading 1 page 111.7KB
Regulatory Filings
2020-08-04 English
Trading halt 2 pages 742.4KB
Regulatory Filings
2020-08-04 English
June Quarterly Activity and Cashflow Report 10 pages 332.1KB
Regulatory Filings
2020-07-30 English
Appendix 2A - Exercise of MXCOE Options 15 pages 175.6KB
Regulatory Filings
2020-07-30 English
Results from ArtemiC Safety and Toxicity Pre-clinical Study 3 pages 193.8KB
Regulatory Filings
2020-07-26 English
Reinstatement to Official Quotation 1 page 74.2KB
Regulatory Filings
2020-07-26 English
Suspension from Official Quotation 2 pages 374.6KB
Regulatory Filings
2020-07-23 English
Pause in Trading 1 page 110.6KB
Regulatory Filings
2020-07-21 English
Trading Halt 2 pages 545.8KB
Regulatory Filings
2020-07-21 English
MGC Pharma to acquire 100% of Medicinal Cannabis Clinic 4 pages 196.3KB
Regulatory Filings
2020-07-19 English
Proposed issue of Securities - MXC 5 pages 28.0KB
Regulatory Filings
2020-07-19 English
Change of Director's Interest Notice - Appendix 3Y x 2 5 pages 103.5KB
Regulatory Filings
2020-07-14 English
MXC Cannabis Research Permit Granted for RMIT Programs 2 pages 178.6KB
Regulatory Filings
2020-07-13 English
Appendix 2A 16 pages 391.3KB
Regulatory Filings
2020-07-09 English
MGC Pharma awarded Import Licence by Office of Drug Control 2 pages 178.8KB
Regulatory Filings
2020-07-07 English
COVID-19 Clinical Trial Site Expansion into India 4 pages 208.8KB
Regulatory Filings
2020-07-01 English
Results of General Meeting 2 pages 639.6KB
Regulatory Filings
2020-07-01 English
MGC Pharma GM Webinar 1 page 167.2KB
Regulatory Filings
2020-06-25 English
INVESTOR PRESENTATION 28 pages 1.7MB
Regulatory Filings
2020-06-23 English
MXC Awarded 3-year EU GMP Manufacturing Licence 2 pages 216.5KB
Regulatory Filings
2020-06-22 English
Unmarketable Parcel Share Sale Facility 5 pages 654.0KB
Regulatory Filings
2020-06-21 English
Sale of MGC Nutra to US CBD and Hemp Wellness Company 3 pages 192.4KB
Regulatory Filings
2020-06-17 English
Binding Term Sheet for distribution of CannEpil in Israel 3 pages 192.6KB
Regulatory Filings
2020-06-14 English
3,250 Prescriptions Milestone Surpassed 3 pages 247.8KB
Regulatory Filings
2020-06-01 English
Notice of General Meeting/Proxy Form 21 pages 514.4KB
Regulatory Filings
2020-05-28 English
Letter to Shareholders - Upcoming General Meeting 3 pages 306.1KB
Regulatory Filings
2020-05-28 English
Ethics Committee Approval for CannEpil Phase IIb Trial 4 pages 228.5KB
Regulatory Filings
2020-05-25 English
Binding Term Sheet Signed for Distribution of ArtemiC 3 pages 193.9KB
Regulatory Filings
2020-05-12 English
Reinstatement to Official Quotation 1 page 409.5KB
Regulatory Filings
2020-05-12 English
Extension of Voluntary Suspension 1 page 150.6KB
Regulatory Filings
2020-05-11 English
Voluntary Suspension 2 pages 559.4KB
Regulatory Filings
2020-05-10 English
Issue of Options - Appendix 2A 16 pages 297.3KB
Regulatory Filings
2020-05-10 English
Pause in Trading 1 page 111.0KB
Regulatory Filings
2020-05-06 English
Trading Halt 2 pages 190.2KB
Regulatory Filings
2020-05-06 English
Phase II Clinical Trial on COVID-19 Patients Commenced 2 pages 180.0KB
Regulatory Filings
2020-05-04 English
Prospectus 36 pages 403.0KB
Regulatory Filings
2020-05-03 English
Proposed issue of Securities - MXC 5 pages 27.4KB
Regulatory Filings
2020-05-03 English
Completion of $3.5m Placement - Appendix 2A 16 pages 299.5KB
Regulatory Filings
2020-05-03 English
March Quarterly Activity and Cashflow Report 10 pages 920.3KB
Regulatory Filings
2020-04-28 English
MGC Pharma Secures Commitments for $3.5m Placement 2 pages 176.8KB
Regulatory Filings
2020-04-27 English
Proposed issue of Securities - MXC 6 pages 31.6KB
Regulatory Filings
2020-04-27 English
Proposed issue of Securities - MXC 5 pages 27.4KB
Regulatory Filings
2020-04-27 English
Second Ethics Committee Approval for Phase II COVID-19 Trial 5 pages 215.2KB
Regulatory Filings
2020-04-27 English
Trading Halt 2 pages 533.2KB
Regulatory Filings
2020-04-23 English
Successful Research Results for MGC on Glioblastoma 5 pages 535.9KB
Regulatory Filings
2020-04-21 English
Pause In Trade 1 page 111.3KB
Regulatory Filings
2020-04-16 English
Phase II Clinical Trial on Patients Diagnosed with COVID-19 10 pages 347.0KB
Regulatory Filings
2020-04-16 English
MGC Pharma Listing Rule 10.19 Correction 1 page 166
Regulatory Filings
2020-04-14 English
MGC Pharma Signs Agreement Targeting Anti-Viral Treatments 5 pages 218.8KB
Regulatory Filings
2020-04-14 English
Reinstatement to Official Quotation 1 page 75.8KB
Regulatory Filings
2020-04-14 English
Suspension from Official Quotation 1 page 75.9KB
Regulatory Filings
2020-04-07 English
MGC Pharma COVID-19 Business and Operations Update 3 pages 185.1KB
Regulatory Filings
2020-04-05 English
Voluntary Suspension Extension 1 page 146.4KB
Regulatory Filings
2020-04-02 English
Voluntary Suspension Extension 1 page 146.4KB
Regulatory Filings
2020-04-01 English
Voluntary Suspension Extension 1 page 176.9KB
Regulatory Filings
2020-03-30 English
Voluntary Suspension Extension 1 page 146.4KB
Regulatory Filings
2020-03-26 English
Voluntary Suspension Extension 1 page 179.0KB
Regulatory Filings
2020-03-25 English
Voluntary Suspension Extension 1 page 146.2KB
Regulatory Filings
2020-03-24 English
Voluntary Suspension Extension 1 page 146.3KB
Regulatory Filings
2020-03-23 English
Suspension from Official Quotation 2 pages 216.2KB
Regulatory Filings
2020-03-22 English
Change of Director's Interest Notice - Appendix 3Y x 2 6 pages 260.4KB
Regulatory Filings
2020-03-22 English
Trading Halt 2 pages 345.1KB
Regulatory Filings
2020-03-18 English
SPP - Appendix 2A 15 pages 175.0KB
Regulatory Filings
2020-03-16 English
Operational Update and Share Purchase Plan Completion 3 pages 214.5KB
Regulatory Filings
2020-03-15 English
Patients Begin Treatment in Clinical Trial of CogniCann 3 pages 188.7KB
Regulatory Filings
2020-03-08 English
Binding Amendment to Supply Agreement with ONIX Brazil 4 pages 207.2KB
Regulatory Filings
2020-03-02 English
Extension of SPP Closing Date 1 page 137.1KB
Regulatory Filings
2020-03-02 English
Trading Halt 2 pages 347.4KB
Regulatory Filings
2020-02-27 English
Half Yearly Report and Accounts 28 pages 673.3KB
Regulatory Filings
2020-02-27 English
Notice Under Section 708A(5)(e) of the Corporations Act 1
Regulatory Filings
2020-02-26 English
Commercial Supply Deal Signed for First Products into Poland 3 pages 222.2KB
Regulatory Filings
2020-02-25 English
Completion of $1m Placement - Appendix 2A 16 pages 334.6KB
Regulatory Filings
2020-02-24 English
85% Increase in Order Volume of New Prescription Products 2 pages 213.9KB
Regulatory Filings
2020-02-20 English
SPP Offer Document and Application Forms Despatched 2 pages 184.0KB
Regulatory Filings
2020-02-19 English
MGC Pharma announces $1m Strategic Placement and $3m SPP 4 pages 204.9KB
Regulatory Filings
2020-02-16 English
Proposed issue of Securities - MXC 11 pages 42.5KB
Regulatory Filings
2020-02-16 English
Notice Under Section 708A(5)(e) of the Corporations Act 1
Regulatory Filings
2020-02-16 English
Security Purchase Plan- Offer Document 9 pages 242.5KB
Regulatory Filings
2020-02-16 English
Trading Halt 2 pages 538.5KB
Regulatory Filings
2020-02-12 English
December Quarterly Activity and Cashflow Report 11 pages 322.1KB
Regulatory Filings
2020-01-30 English
Agreement Signed with Leading Peruvian Distributor 3 pages 215.0KB
Regulatory Filings
2020-01-27 English
Company Presentation for UK and Australian Investors 25 pages 2.4MB
Regulatory Filings
2020-01-16 English
MGC Pharma Crosses 2,000 Prescription Milestone 3 pages 238.1KB
Regulatory Filings
2020-01-08 English
Launch of New Product Line in Aus & NZ - Mercury Pharma 2 pages 202.7KB
Regulatory Filings
2020-01-06 English
Change of Director's Interest Notice - Appendix 3Y x 2 5 pages 103.4KB
Regulatory Filings
2020-01-01 English